Who is sponsoring NCT03886025?

NCT03886025 is sponsored by Dr. Najat Khalifa.

What drugs are being tested in NCT03886025?

Interventions in NCT03886025: Anodal transcranial Direct Current Stimulation (tDCS), Cognitive training, Sham transcranial Direct Current Stimulation (tDCS).

What condition does NCT03886025 study?

NCT03886025 studies Impulsivity, Decision Making.

Is NCT03886025 still recruiting?

NCT03886025 is currently recruiting now. Last updated 8 August 2025.

Last reviewed 2025-08-08 · How we verify

NCT03886025: tDCS-CTDM

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Combined Anodal Transcranial Direct Current Stimulation (tDCS) and Cognitive Training and Decision-making

Recruiting now NA Last updated 8 August 2025

What this trial tests

NA trial testing Anodal transcranial Direct Current Stimulation (tDCS) in Impulsivity in 60 participants. Currently enrolling.

Timeline

15 September 2022

Primary endpoint
30 December 2026

30 December 2026

Quick facts

Lead sponsor	Dr. Najat Khalifa
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	60
Start date	15 September 2022
Primary completion	30 December 2026
Estimated completion	30 December 2026
Sites	1 location across Canada

Drugs / interventions tested

Anodal transcranial Direct Current Stimulation (tDCS)
Cognitive training
Sham transcranial Direct Current Stimulation (tDCS)

Conditions studied

Impulsivity — all drugs for Impulsivity →
Decision Making — all drugs for Decision Making →

Sponsor

Dr. Najat Khalifa

Who can join

Adults 18 to 40, any sex, with Impulsivity or Decision Making. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to (i) assess the effects of combined tDCS and cognitive training on decision-making on a trained task (Iowa Gambling Task; IGT); and (ii) test generalization to a closely related cognitive domain, namely motor impulsivity. It is hypothesized that combined anodal tDCS and cognitive training will result in more advantageous decisions and better impulse control than combined sham tDCS and cognitive training.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Impulsivity

Currently open trials in the same condition.

NCT07399964 — Effects of CBT-I on Impulsivity and Risk Taking in Youths With Insomnia · NA · recruiting
NCT05647044 — Frontal iTBS for Impulsivity and Suicidal Ideation in Veterans With Mild Traumatic Brain Injury · Phase 1 · recruiting

Other Dr. Najat Khalifa trials

Trials by the same sponsor.

NCT04732052 — The Use of Transcranial Direct Current Stimulation (tDCS) in Adults With Developmental Disabilities · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03886025 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Dr. Najat Khalifa
Last refreshed: 8 August 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03886025.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing